Vitamin Shoppe (NYSE:VSI)

CAPS Rating: 3 out of 5

Results 1 - 12 of 12

Recs

0
Member Avatar tjacobx (< 20) Submitted: 5/27/2014 6:10:18 PM : Outperform Start Price: $42.77 VSI Score: -13.17

vsi

Recs

0
Member Avatar rknapton (< 20) Submitted: 8/22/2013 5:22:17 PM : Outperform Start Price: $41.22 VSI Score: -27.04

Long. Only vitamin company I like. Still growing good. Great balance sheet.

Recs

3
Member Avatar TMF1000 (99.70) Submitted: 6/3/2013 10:33:07 AM : Outperform Start Price: $44.22 VSI Score: -34.07

I added VSI to caps at a price of $44.22. The PE ratio was 21.16. Sales grew 12.5% while net income per share grew 11.5%. A recent acquisition was partially responsible for the slowness in net income growth. Excluding the $0.04 charge net income per share grew 18%. I think the drop over the last two quarters haven't been rational. the fourth quarter saw the largest drop in the stock price. But they have an $0.08 impact from Hurricane Sandy and a new acquisition, and start up costs in Canada. I feel those are very good reasons for net income to be flat in the fourth quarter. Those quarters are behind them and they should start to pick up steam from here. Same store sales are healthy and were healthy during the last two quarters. They have only 621 stores compared to 8500 for GNC the largest company in the industry. Both of these companies have great cash flow.

Vitamin Shoppe has generated $45.92 million or $1.51 per share over the last 12 months. And that should improve next year barring any new hurricanes. I don't see any problems integrating their acquisitions. They have $45 million in cash and no debt.

This is a baby boomer play. As baby boomers get older they are taking more supplements.This is a highly fragmented industry with no one having more than 5% of the market. I believe VSI can take market share from the smaller players and if they also succeed in grabbing market share from GNC they could grow for many years and decades. GNC won't just sit still. Regardless for the next five years, VSI should do well.

They compete with drug stores and the Wal-Mart of the world, but I am not sure that those are the places that people first go to shop for vitamins. I think VSI can through the use of knowledgeable employees drive sales for many years to come.

Vitamin Shoppe (VSI)

February 16, 2011 4Q:2010 earnings’ highlights:
** Revenue for the fourth quarter $180.276 million up from $162.398 million
** Revenue for fiscal 2010 was $751.482 million up from $674.495 million
** TTM revenue was $751.482 million or $26.01 per share
** 4Q earnings were $0.21 up from $0.04
** Fiscal 2010 earnings were $1.03 up from $0.28
** Same store sales up 6.5%: store 484
** Diluted share count 28.89 million
** Cash flow for the year was $36.8 million up from $22.19 million
** TTM cash flow was $36.8 million or $1.27 per share
** Capital expenditures for the year was $18.356 million down from $21.244 million
** Trading range between February 16, 2011 and April 26, 2011 was $30.93 to $37.09: PE ratio range was 30.02 to 36: PS ratio range was 1.19 to 1.43: Cash flow yield range was 3.4% to 4.1%

April 26, 2011 1Q:2011 earnings highlights:
** Revenue was $216.852 million up from $191.613 million
** TTM revenue was $776.7 million or $26.52 per share
** Earnings were $0.40 up from $0.31
** TTM earnings were $1.12
** Diluted share count 29.294 million
** Same store sales were up 8.1%: 497 stores
** Cash flow for the quarter was $6.437 million up from 2.77 million
** TTM cash flow was $40.47 million or $1.38 per share
** Trading range between April 26, 2011 and July 28, 2011 was $36.80 to $48.36: PE ratio range was 32.86 to 43.18: PS Ratio range was 1.39 to 1.82: Cash flow yield range was 2.9% to 3.8%

July 28, 2011 2Q:2011 earnings’ highlights:
** Revenue was $215.942 million up from $192.234 million
** TTM revenue was $800.41 million or $27.10 per share
** Earnings were $0.40 up from $0.26
** TTM earnings were $1.26 per share
** Diluted share count 29.539 million
** Same store sales were up 8%: 505 stores
** Cash flow for six months was $25.35 million up from $6.243 million
** TTM cash flow was $55.91 million or $1.89 per share
** Trading range between July 28, 2011 and October 26, 2011 was $34.49 to $46.40: PE ratio range was 27.37 to 36.83: PS ratio range was 1.27 to 1.71: Cash flow yield range was 4.1% to 5.5%

October 26, 2011 3Q:2011 earnings’ highlights:
** Revenue was $208.936 million up from $187.359 million
** TTM revenue was $821.99 million or $27.68 per share
** Earnings were $0.40 up from $0.25
** TTM earnings were $1.41 per share
** Diluted share count 29.694 million
** Same store sales were up 7.1%: 515 stores
** Cash flow for nine months was $46.8 million up from $28.5 million
** TTM cash flow was $55.1 million or $1.86 per share
** Trading range between October 26, 2011 and February 28, 2012 was $34.82 to $44.95: PE ratio range was 24.7 to 31.88: PS ratio range was 1.17 to 1.62: Cash flow yield range was 4.1% to 5.34%

February 28, 2012 4Q:2011 earnings’ highlights:
** Revenue $214.856 million up from $180.276 million
** TTM revenue was $856.586 million up from $751.482 million
** TTM revenue was $856.586 million or $28.84 per share
** Earnings were $0.32 up from $0.21
** TTM earnings were $1.52 up from $1.03
** Diluted share count 29.698 million
** Cash $10.754 million: Debt 0
** Cash flow for the year was $52.87 million or $1.78 per share
** Same store sales up 6.5%: 528
** Trading range between February 28, 2012 and May 8, 2012 was $41.62 to $49.27: PE ratio range was 27.38 to 32.41: PS ratio range was 1.44 to 1.71: Cash flow yield range was 3.6% to 4.3%

May 8, 2012 1Q:2012 earnings’ highlights:
** Revenue was $248.051 million up from $216.852 million
** TTM revenue was $887.785 million or 29.77 per share
** Earnings were $0.61 up from $0.40
** TTM earnings were $1.73 per share
** Diluted share count 29.818 million
** Cash flow for the quarter was $990,000 down from $6.4 million
** TTM cash flow was $47.46 million or $1.59 per share
** Same store sales up 9.6%: stores 543
** Trading range between May 8, 2012 and August 7, 2012 was $47.86 to $58.88: PE ratio range was 27.66 to 34.03: PS ratio range was 1.61 to 1.98: Cash flow yield range was 2.7% to 3.3%

August 7, 2012 2Q:2012 earnings’ highlights:
** Revenue was $244.981 million up from $215.942 million
** TTM revenue was $916.82 or 30.65 per share
** Earnings were $0.55 up from $0.44
** TTM earnings were $1.84 per share
** Diluted share count 29.918 million
** Cash $50.436 million: debt 0
** Cash flow for six months was $28.54 million up from $25.4 million
** TTM cash flow was $56.01 million or $1.87 per share
** Same store sales were up 8.3%: stores 551
** Gross margins 35%: Operating margins were 11.3%
** Trading range between August 7, 2012 and November 6, 2012 was $52.90 to $61.83: PE ratio range was 28.75 to 33.6: PS ratio range was 1.76 to 2.02: Cash flow yield range was 3% to 3.5%

November 6, 2012 3Q: 2012 earnings highlights:
** Revenue was $238.994 million up from $208.936 million
** TTM revenue was $946.88 million or $31.31 per share
** Earnings were $0.54 up from $0.40
** TTM earnings were $1.98
** Diluted share count 30.244 million
** Cash flow for nine months $42.3 million down from $46.8 million
** TTM cash flow was $48.37 million or $1.60
** Trading range between November 6, 2012 and February 26, 2013 was $53.39 to $64.93: PE ratio range was 26.96 to 32.79: PS ratio range was 1.71 to 2.07: Cash flow yield range was 2.46% to 3%

February 26, 2013 4Q:2012 earnings’ highlights:
** 4Q revenue was $218.876 million up from $214.856 million
** Fiscal 2012 revenue was $950.902 million up from $856.586 million
** TTM revenue per share was $31.06 per share
** 4Q earnings were $0.32 flat with last year $0.32
** Fiscal 2012 earnings were $2.02 up from $1.52
** Diluted share count 30.461 million
** Cash flow for the year was $47.6 million down from $52.1 million
** Cash flow per share was $1.56 per share
** Same store sale was up 5.2% which include an estimated 1.6% impact from hurricane sandy.
** Store 580 Vitamin shoppe stores: 31 Super Supplement stores acquired
** Trading range between February 26, 2013 and May 7, 2013 was $44.90 to $56.80: PE ratio range was 22.23 to 28.12: PS ratio range was 1.45 to 1.83: Cash flow yield range was 2.8% to 3.5%
** Special Note: The stock fell $11.78 the day of the report to close at $51.44 on February 26, 2013: The report was announced before the market opened.

May 7, 2013 1Q:2013 earnings’ highlights:
** Revenue was $279.087 million up 12.5% from $248.051 million
** TTM Revenue was $981.938 million or $32.20 per share
** Earnings were $0.68 up from $0.61
** TTM earnings were $2.09
** Diluted share count 30.495 million
** Cash $31.213 million: debt 0
** Cash flow for the quarter was negative ($693,000) down from $990,000
** TTM Cash flow was $45.92 million or $1.51 per share
** Same store sales up 4.5% Stores 621 Including 2 in Canada
** Trading range between May 7, 2013 and the present June 1, 2013 was $43.16 to $47.50:
** Special Note: the stock price fell $4.08 the day of the report May 7, 2013 to close at $45.23: They announced before the market opened.

At the time GNC is selling for $44.49 - I wanted to note that.

Recs

0
Member Avatar andrewstrate (62.64) Submitted: 3/18/2013 12:45:55 PM : Outperform Start Price: $51.86 VSI Score: -53.60

Growing demand, what someone needs to do is merge these type establishments with FROYO craze. Seems your targeting the right custmer base.

Recs

0
Member Avatar stocky5 (36.42) Submitted: 2/26/2013 10:23:21 AM : Outperform Start Price: $53.70 VSI Score: -61.33

Great buying opportunity on today's news of earnings only meeting analyst estimates. The price drop is an over-reaction, and illustrates this company's prior performance of always exceeding estimates. Great long term holding.

Recs

1
Member Avatar Loerke (91.76) Submitted: 7/23/2012 11:41:49 PM : Underperform Start Price: $54.43 VSI Score: +76.46

The only vitamin chain with a legit niche is GNC, because Guidos are everywhere. Everyone else is just a regular vitamin seller. Why spend discretionary money here instead of elsewhere for products that probably don't work?

Recs

0
Member Avatar SFInvestmentClub (< 20) Submitted: 12/4/2011 5:06:08 PM : Outperform Start Price: $39.12 VSI Score: -58.06

E. Chung likes it because the top and bottom line have grown consistently. No debt.

Recs

0
Member Avatar airenInDebt (71.17) Submitted: 2/3/2011 3:12:07 PM : Outperform Start Price: $31.78 VSI Score: -30.10

More people looking for alternative treatments will continue making the supplement industry grow. Also, the stores large selection and fair pricing makes it the best brick and mortar store available. Online sales can only help it's bottom line. I don't look at the financials to make my decisions, just common sense

Recs

1
Member Avatar XMFGatsby1 (97.29) Submitted: 7/16/2010 6:25:35 PM : Outperform Start Price: $21.43 VSI Score: +8.74

Much larger in-store selection than GNC which includes more reasonably priced products.

Recs

1
Member Avatar Superdrol (97.25) Submitted: 2/14/2010 3:02:41 PM : Underperform Start Price: $21.55 VSI Score: +2.52

Expensive discretionary products.

Recs

0
Member Avatar chrismil15 (< 20) Submitted: 11/15/2009 3:55:33 PM : Outperform Start Price: $20.39 VSI Score: +10.37

Having been a customer for years I believe they will outpace the competition due to their lower prices and availability of products. Looking at the balance sheet and growth plans I believe this company is undervalued and will perform extremely well. I'm holding this one for the long run.

Recs

0
Member Avatar MRSTARBUCKS (99.13) Submitted: 11/3/2009 4:34:00 PM : Outperform Start Price: $19.10 VSI Score: +14.95

a good stock

Results 1 - 12 of 12

Featured Broker Partners


Advertisement